More M&A: Forest snags Furiex for $1.1B as Meda stiff-arms Mylan’s $9B bid

Tracy Staton

Pharma's M&A fever may be most obvious among the industry's biggest players, but smaller companies are making their own bids, transformational and otherwise.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS